Bladder Cancer Drugs Market Research Reports

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Drug Analysis: Imfinzi - Product Thumbnail Image

Drug Analysis: Imfinzi

  • Drug Pipelines
  • 41 Pages
From
Bladder Cancer Forecast in 18 Major Markets 2016-2026 - Product Thumbnail Image

Bladder Cancer Forecast in 18 Major Markets 2016-2026

  • Report
  • 66 Pages
From
CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report - Product Thumbnail Image

CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report

  • Report
  • 2001 Pages
CAS 25316-40-9 Doxorubicin hydrochloride Chemical World Report - Product Thumbnail Image

CAS 25316-40-9 Doxorubicin hydrochloride Chemical World Report

  • Report
  • 2005 Pages
Global Bladder Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Bladder Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • 2091 Pages
CAS Mitomycin C World Consumption Report - Product Thumbnail Image

CAS Mitomycin C World Consumption Report

  • Report
  • 2177 Pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • 2095 Pages
CAS 15663-27-1 Cisplatin Chemical World Report - Product Thumbnail Image

CAS 15663-27-1 Cisplatin Chemical World Report

  • Report
  • 2157 Pages
CAS 23214-92-8 Adriamycin Chemical World Report - Product Thumbnail Image

CAS 23214-92-8 Adriamycin Chemical World Report

  • Report
  • 2153 Pages
CAS 50-18-0 Cyclophosphamide Chemical World Report - Product Thumbnail Image

CAS 50-18-0 Cyclophosphamide Chemical World Report

  • Report
  • 2011 Pages
World Urinary Tract CancerMarket - Opportunities and Forecasts, 2017 - 2023 - Product Thumbnail Image

World Urinary Tract CancerMarket - Opportunities and Forecasts, 2017 - 2023

  • Report
From
CAS 95056-36-3 N-7-(2-(Nitrophenyldithio)ethyl)mitomycin C Chemical World Report - Product Thumbnail Image

CAS 95056-36-3 N-7-(2-(Nitrophenyldithio)ethyl)mitomycin C Chemical World Report

  • Report
  • 2121 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • 2111 Pages
CAS 50-07-7 Mitomycin C Chemical World Report - Product Thumbnail Image

CAS 50-07-7 Mitomycin C Chemical World Report

  • Report
  • 2064 Pages
US Bladder Cancer Market and Competitive Landscape - 2018 - Product Thumbnail Image

US Bladder Cancer Market and Competitive Landscape - 2018

  • Report
From
Global Bladder Cancer Market and Competitive Landscape - 2018 - Product Thumbnail Image

Global Bladder Cancer Market and Competitive Landscape - 2018

  • Report
From
Europe Bladder Cancer Market and Competitive Landscape - 2018 - Product Thumbnail Image

Europe Bladder Cancer Market and Competitive Landscape - 2018

  • Report
From
Loading Indicator

Bladder cancer is the fourth most common cancer among males in the US and due to its prevalence among the over 65s, diagnoses are set to increase in ageing populations worldwide. Reports in the Bladder Cancer section cover a variety of areas, such as the latest R&D and clinical trials taking place in universities, hospitals and other research centres around the world. Explore epidemiology, unmet needs, drug development (cytotoxic, immunotherapy agents, etc.), supply & demand, business development strategies, licensing and partnership opportunities, and the activities of key industry players such as Bristol-Myers Squibb, Spectrum Pharmaceuticals, Bioniche Life Sciences, Endo Pharmaceuticals, Eli Lilly and Sanofi-Aventis. Show Less Read more

adroll